Indapamide Sandoz (Indapamide)

Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, decreasing reabsorption of these ions. This leads to increased urine output, reduced blood volume, and lower peripheral vascular resistance through direct vasodilation, together producing antihypertensive and diuretic effects.

The appropriate dose of Indapamide Sandoz is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Indapamide during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Indapamide Sandoz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering both diuretic and vasodilatory actions. Compared with classic thiazides, it has a longer duration of action and may cause fewer metabolic disturbances, while still effectively lowering blood pressure and managing edema. It is often chosen when a combined antihypertensive‑diuretic effect is desired.

Store Indapamide Sandoz at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Indapamide Sandoz is taken orally, usually once daily in the morning with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed.

Serious adverse events include severe dehydration, acute kidney injury, significant electrolyte imbalances such as hyponatremia or hypokalemia, and allergic reactions like rash or angioedema. Patients should seek immediate medical attention if they experience symptoms such as rapid weight loss, muscle weakness, confusion, or swelling of the face and throat.

Indapamide is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide-derived drugs, severe renal impairment, and in individuals with anuria. Caution is also advised for patients with uncontrolled diabetes, gout, or those taking medications that may interact adversely.